RO Roche Holding AG

482.72USD406.80 CHF · SWX-0.20%Mkt Cap: 382.91B USDP/E: 26.42

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas o…

Institutional holders11 on file

Key Statistics

Company
Market Cap382.91B USD
Enterprise Value415.66B USD
Revenue (TTM)74.71B USD
Gross Profit55.43B USD
Net Income (TTM)15.28B USD
Revenue/Share93.86 USD
Last Price482.72 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees—
CountryCH
SectorHealthcare
IndustryDrug Manufacturers - General
ISINCH0012032113
Valuation
P/E (Trailing)26.42
P/E (Forward)18.34
PEG1.81
EV/EBITDA14.62
EV/Revenue5.56
P/S5.13
P/B9.87
EPS (TTM)18.19 USD
EPS (Forward)26.21 USD
52W Range
352.6791% of range495.77
52W High495.77 USD
52W Low352.67 USD
Profitability
Gross Margin73.73%
Oper. Margin33.12%
EBITDA Margin38.06%
Profit Margin20.33%
ROE38.10%
ROA12.79%
ROIC27.02%
ROCE25.41%
Growth
Revenue Growth-1.20%
Earnings Growth-7.70%
Cash Flow & Leverage
Operating CF22.37B USD
CapEx (TTM)6.86B USD
FCF Margin16.39%
FCF Yield3.20%
Net Debt27.97B USD
Net Debt/EBITDA0.98
Net Debt/FCF2.28
Balance Sheet
Debt/Equity0.98
Current Ratio1.23
Quick Ratio0.80
Book Value/Sh48.69 USD
Cash/Share14.50 USD
Dividends
Fwd Div Rate11.63 USD
Trail. Div Rate11.63 USD
Div. Yield2.40%
5Y Avg Yield2.98%
Payout Ratio63.93%
Ex-Div DateMar 12, 2026
Pay DateMar 31, 2025
Splits
Last Split100:1
Split DateMay 4, 2001
Analyst Consensus
Rating—
Target (Mean)557.72 USD
Upside (mean)+15.5%
Target Range522.12 USD – 593.31 USD
522.12+15.5% to mean593.31
# Analysts2
Ownership
Shares Out.106.69M
Float723.67M
Insiders72.31%
Institutions12.06%
Technical
SMA 50456.48 (+5.7%)
SMA 200420.78 (+14.7%)
Beta0.32
S&P 52W Chg12.00%
Avg Vol (30d)28.36K
Avg Vol (10d)29.05K
Technical Indicators
RSI (14)55.2
MACD6.8166
MACD Signal8.1663
MACD Hist.-1.3497
BB Upper495.51 USD
BB Middle482.68 USD
BB Lower469.86 USD
BB Width5.31%
ATR (14)7.908 USD
Vol Ratio (20d)1.05x

About Roche Holding (SWX: RO)

›

Roche Holding (SWX: RO) is listed on the SIX Swiss Exchange, where its shares trade in CHF. It belongs to the Drug Manufacturers - General industry, part of the Healthcare sector.

The shares were at 406.80 CHF on 19 November 2026, up 39.9% over 52 weeks. Its 52-week range is 297.20 CHF to 417.80 CHF: the price is 2.6% below the high and 36.9% above the low.

At a market capitalisation of 322.69B CHF, it trades at 26.4 times trailing earnings and 18.3 times forward earnings. The median trailing P/E of its 17 largest Drug Manufacturers - General peers is 25.4, so RO is valued in line with them. It pays a dividend yielding 2.40% (it pays out 64% of its earnings), against a median of 2.68% among the dividend payers in that peer group.

Roche Holding reports return on equity of 38.1%, an operating margin of 33.1% and revenue down 1.2% year over year.

Its debt exceeds its cash by 23.57B CHF, a debt-to-equity ratio of 0.98. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 2 analysts cover the stock; their mean price target of 470.00 CHF is 15.5% above the current price.